Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by skier59on Dec 22, 2020 7:57am
144 Views
Post# 32159276

RE:On reflection

RE:On reflectionThe company had better issue the quarterly update early January. I thought we were finally going to hold 20, and it pisses me off that we dropped back below that number. I'm hoping we will see a few more treated to up the number closer to 20. I'd also like to see that whoever is in charge of the COVID Virus Study has submitted a request for funds be it a grant or whatever, so that we don't have to cover the costs, and the Market would drop that thought from future expenditures of the company. That alone, could send to SP on a run by itself. Our monthly burn rate is currently at a very low conservative number, which bolds very well for getting to commercialization on NMIBC if the second 12 pack is treated properly, and the numbers produced are what we all expect, something far greater than 67% which will give us BTD. I don't expect any news this week or next, but early January might be a good time to add to the TFSA.
<< Previous
Bullboard Posts
Next >>